Ocugen, Inc.

Ocugen, Inc.verified

OCGN

Price:

$1.21

Market Cap:

$409.61M

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis. OCU410: Another gene therapy candidate, currently being developed to address dry age-related macular degeneration (AMD). OCU200: A novel fusion protein, presently undergoing preclini...[Read more]

Industry

Biotechnology

IPO Date

2014-12-03

Stock Exchange

NASDAQ

Ticker

OCGN

The ROE as of June 2026 (TTM) for Ocugen, Inc. (OCGN) is -127987.50%

According to Ocugen, Inc.’s latest financial reports and current stock price. The company's current ROE is -127987.50%. This represents a change of 41.34% compared to the average of -308.82% of the last 4 quarters.

Ocugen, Inc. (OCGN) Historical ROE (quarterly & annually)

How has OCGN ROE performed in the past?

The mean historical ROE of Ocugen, Inc. over the last ten years is 175.86%. The current -127987.50% ROE has changed -72878.51% with respect to the historical average. Over the past ten years (40 quarters), OCGN's ROE was at its highest in in the December 2018 quarter at 178.60%. The ROE was at its lowest in in the June 2017 quarter at -811.66%.

Quarterly (TTM)
Annual

Average

175.86%

Median

-109.30%

Minimum

-183.72%

Maximum

1.89%

Ocugen, Inc. (OCGN) ROE by Quarter and Year

Discovering the peaks and valleys of Ocugen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 705.03%

Maximum Annual ROE = 1.89%

Minimum Annual Increase = -405.71%

Minimum Annual ROE = -183.72%

Quarterly (TTM)
Annual
YearROEChange
2025557.67%-405.71%
2024-182.42%17.31%
2023-155.50%32.53%
2022-117.33%92.63%
2021-60.91%-39.85%
2020-101.26%-44.88%
2019-183.72%-109.74%
20181.89%705.03%
2017234.42%-296.22%
2016-119.47%5.19%

Ocugen, Inc. (OCGN) Average ROE

How has OCGN ROE performed in the past?

The current ROE of Ocugen, Inc. (OCGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

73.25%

5-year avg

8.30%

10-year avg

175.86%

Ocugen, Inc. (OCGN) ROE vs. Peers

How is OCGN’s ROE compared to its peers?

Ocugen, Inc.’s ROE is less than Fulcrum Therapeutics, Inc. (-27.80%), less than Lineage Cell Therapeutics, Inc. (-152.10%), less than Neurogene Inc. (-37.88%), less than Neumora Therapeutics, Inc. Common Stock (-181.70%), less than Omeros Corporation (-54.39%), less than Compass Therapeutics, Inc. (-39.75%), less than ADC Therapeutics S.A. (65.27%), less than Lexicon Pharmaceuticals, Inc. (-18.64%), less than Alumis Inc. Common Stock (-54.63%), less than RAPT Therapeutics, Inc. (-61.81%),

Build a custom stock screener for Ocugen, Inc. (OCGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocugen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocugen, Inc. (OCGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocugen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ocugen, Inc.'s ROE?

How is the ROE calculated for Ocugen, Inc. (OCGN)?

What is the highest ROE for Ocugen, Inc. (OCGN)?

What is the 3-year average ROE for Ocugen, Inc. (OCGN)?

What is the 5-year average ROE for Ocugen, Inc. (OCGN)?

How does the current ROE for Ocugen, Inc. (OCGN) compare to its historical average?